Neo Ivy Capital Management’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,456
| Closed | -$503K | – | 409 |
|
|
2025
Q1 | $503K | Buy |
1,456
+253
| +21% | +$87.4K | 0.16% | 196 |
|
|
2024
Q4 | $361K | Buy |
+1,203
| New | +$361K | 0.07% | 182 |
|
|
2024
Q3 | – | Sell |
-940
| Closed | -$302K | – | 321 |
|
|
2024
Q2 | $302K | Buy |
+940
| New | +$302K | 0.06% | 190 |
|
|
2022
Q3 | – | Sell |
-1,915
| Closed | -$321K | – | 447 |
|
|
2022
Q2 | $321K | Sell |
1,915
-215
| -10% | -$36K | 0.86% | 18 |
|
|
2022
Q1 | $534K | Buy |
2,130
+1,438
| +208% | +$361K | 0.48% | 62 |
|
|
2021
Q4 | $178K | Sell |
692
-684
| -50% | -$176K | 0.26% | 150 |
|
|
2021
Q3 | $134K | Buy |
+1,376
| New | +$134K | 0.15% | 205 |
|
|
2020
Q3 | – | Sell |
-1,376
| Closed | -$134K | – | 526 |
|
|
2020
Q2 | $134K | Sell |
1,376
-917
| -40% | -$89.3K | 0.15% | 205 |
|
|
2020
Q1 | $206K | Buy |
+2,293
| New | +$206K | 0.34% | 110 |
|
|
2019
Q4 | – | Sell |
-711
| Closed | -$85K | – | 317 |
|
|
2019
Q3 | $85K | Buy |
+711
| New | +$85K | 0.06% | 236 |
|
|
2019
Q2 | – | Sell |
-4,030
| Closed | -$525K | – | 331 |
|
|
2019
Q1 | $525K | Buy |
+4,030
| New | +$525K | 0.3% | 149 |
|